• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓扑深度学习:代谢功能障碍相关脂肪性肝病胃肠病学的新维度

Topological Deep Learning: A New Dimension in Gastroenterology for Metabolic Dysfunction-Associated Fatty Liver.

作者信息

Singh Yashbir, Ammar Ranya, Shehata Mostafa

机构信息

Radiology, Mayo Clinic, Rochester, USA.

Pediatric Medicine, New Medical Centre Hospital, Abu Dhabi, ARE.

出版信息

Cureus. 2024 May 17;16(5):e60532. doi: 10.7759/cureus.60532. eCollection 2024 May.

DOI:10.7759/cureus.60532
PMID:38764708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11101912/
Abstract

Topological deep learning (TDL) introduces a novel approach to enhancing diagnostic and monitoring processes for metabolic dysfunction-associated fatty liver disease (MAFLD), a condition that is increasingly prevalent globally and a leading cause of liver transplantation. This editorial explores the integration of topology, a branch of mathematics focused on spatial properties preserved under continuous transformations, with deep learning models to improve the accuracy and efficacy of MAFLD diagnosis and staging from medical imaging. TDL's ability to recognize complex patterns in imaging data that traditional methods might miss can lead to earlier and more precise detection, personalized treatment, and potentially better patient outcomes. Challenges remain, particularly regarding the computational demands and the interpretability of TDL outputs, which necessitate further research and development for clinical application. The potential of TDL to transform the gastroenterological landscape marks a significant step toward the incorporation of advanced mathematical methodologies in medical practice.

摘要

拓扑深度学习(TDL)引入了一种新方法,用于加强代谢功能障碍相关脂肪性肝病(MAFLD)的诊断和监测过程。MAFLD在全球范围内日益普遍,是肝移植的主要原因。这篇社论探讨了拓扑学(数学的一个分支,专注于连续变换下保持的空间特性)与深度学习模型的整合,以提高医学成像中MAFLD诊断和分期的准确性和有效性。TDL识别传统方法可能遗漏的成像数据中复杂模式的能力,可实现更早、更精确的检测、个性化治疗,并可能带来更好的患者预后。挑战依然存在,特别是在计算需求和TDL输出的可解释性方面,这需要进一步的研发以用于临床应用。TDL改变胃肠病学领域的潜力标志着在医学实践中纳入先进数学方法迈出了重要一步。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e7/11101912/4a8d9508f68d/cureus-0016-00000060532-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e7/11101912/4a8d9508f68d/cureus-0016-00000060532-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e7/11101912/4a8d9508f68d/cureus-0016-00000060532-i01.jpg

相似文献

1
Topological Deep Learning: A New Dimension in Gastroenterology for Metabolic Dysfunction-Associated Fatty Liver.拓扑深度学习:代谢功能障碍相关脂肪性肝病胃肠病学的新维度
Cureus. 2024 May 17;16(5):e60532. doi: 10.7759/cureus.60532. eCollection 2024 May.
2
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease.肌肉力量与非酒精性脂肪性肝病/代谢相关脂肪性肝病。
World J Gastroenterol. 2024 Feb 21;30(7):636-643. doi: 10.3748/wjg.v30.i7.636.
3
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies.代谢相关脂肪性肝病:发病机制、诊断方法及治疗策略的选择性综述
Front Med (Lausanne). 2024 Jan 23;11:1291501. doi: 10.3389/fmed.2024.1291501. eCollection 2024.
4
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus.从代谢功能障碍相关脂肪性肝病到代谢功能障碍相关脂肪性肝病:争议与共识
World J Hepatol. 2023 Dec 27;15(12):1253-1257. doi: 10.4254/wjh.v15.i12.1253.
5
CT-based methods for assessment of metabolic dysfunction associated with fatty liver disease.基于 CT 的方法评估与脂肪肝相关的代谢功能障碍。
Eur Radiol Exp. 2023 Nov 21;7(1):72. doi: 10.1186/s41747-023-00387-0.
6
Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact.代谢相关脂肪性肝病:新命名及其影响。
World J Gastroenterol. 2023 Jan 21;29(3):549-560. doi: 10.3748/wjg.v29.i3.549.
7
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic.FIB-4在全球代谢紊乱时代代谢功能障碍相关脂肪性肝病诊断算法中居首位。
Life (Basel). 2021 Feb 14;11(2):143. doi: 10.3390/life11020143.
8
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病的流行病学、自然史及诊断:与非酒精性脂肪性肝病的比较性综述
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139650. doi: 10.1177/20420188221139650. eCollection 2022.
9
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.儿童脂肪性肝病(MAFLD/PeFLD 2型):独特的分类考量与挑战
Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388. eCollection 2023.
10
Applications of interpretability in deep learning models for ophthalmology.深度学习模型在眼科领域的可解释性应用。
Curr Opin Ophthalmol. 2021 Sep 1;32(5):452-458. doi: 10.1097/ICU.0000000000000780.

引用本文的文献

1
Computed tomography-based radiomics and body composition model for predicting hepatic decompensation.基于计算机断层扫描的放射组学和身体成分模型预测肝失代偿。
Oncotarget. 2024 Nov 22;15:809-813. doi: 10.18632/oncotarget.28673.

本文引用的文献

1
Advancing Precision Medicine: Algebraic Topology and Differential Geometry in Radiology and Computational Pathology.推进精准医学:放射学和计算病理学中的代数拓扑和微分几何。
Lab Invest. 2024 Jun;104(6):102060. doi: 10.1016/j.labinv.2024.102060. Epub 2024 Apr 16.
2
Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease.儿童非酒精性脂肪性肝病的多模态、多维度特征分析
Metabolites. 2023 Aug 8;13(8):929. doi: 10.3390/metabo13080929.
3
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.
全球非酒精性脂肪性肝病发病率:63 项研究和 1,201,807 人的系统评价和荟萃分析。
J Hepatol. 2023 Aug;79(2):287-295. doi: 10.1016/j.jhep.2023.03.040. Epub 2023 Apr 9.
4
Topological data analysis in medical imaging: current state of the art.医学成像中的拓扑数据分析:当前技术现状
Insights Imaging. 2023 Apr 1;14(1):58. doi: 10.1186/s13244-023-01413-w.
5
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
6
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.